Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzia Capelletti

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Cancer Research|April 2, 2017
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 InhibitorsTakayuki Kosaka, Junko Tanizaki, Raymond M Paranal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinomaMarzia Capelletti, Michael E Dodge, Dalia Ercan, et al.
Molecular Oncology|March 20, 2020
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterationsAtsuko Ogino, Jihyun Choi, Mika Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2013
Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistanceNeil Johnson, Shawn F Johnson, Wei Yao, et al.
Leukemia|June 22, 2018
Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow nicheShokichi Tsukamoto, Marianne B Løvendorf, Jihye Park, et al.
Plos One|October 5, 2018
Profiling of circulating exosomal miRNAs in patients with Waldenström MacroglobulinemiaJuliette M Bouyssou, Chia-Jen Liu, Mark Bustoros, et al.
The New England Journal of Medicine|October 29, 2010
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumorJames E Butrynski, David R D'Adamo, Jason L Hornick, et al.
Cancer Cell|March 12, 2015
A functional landscape of resistance to ALK inhibition in lung cancerFrederick H Wilson, Cory M Johannessen, Federica Piccioni, et al.
Haematologica|February 4, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia modelDina Stroopinsky, Jessica Liegel, Manoj Bhasin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapyFrances A Shepherd, Caroline Domerg, Pierre Hainaut, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Cancer Research|April 2, 2017
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 InhibitorsTakayuki Kosaka, Junko Tanizaki, Raymond M Paranal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinomaMarzia Capelletti, Michael E Dodge, Dalia Ercan, et al.
Molecular Oncology|March 20, 2020
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterationsAtsuko Ogino, Jihyun Choi, Mika Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2013
Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistanceNeil Johnson, Shawn F Johnson, Wei Yao, et al.
Leukemia|June 22, 2018
Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow nicheShokichi Tsukamoto, Marianne B Løvendorf, Jihye Park, et al.
Plos One|October 5, 2018
Profiling of circulating exosomal miRNAs in patients with Waldenström MacroglobulinemiaJuliette M Bouyssou, Chia-Jen Liu, Mark Bustoros, et al.
The New England Journal of Medicine|October 29, 2010
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumorJames E Butrynski, David R D'Adamo, Jason L Hornick, et al.
Cancer Cell|March 12, 2015
A functional landscape of resistance to ALK inhibition in lung cancerFrederick H Wilson, Cory M Johannessen, Federica Piccioni, et al.
Haematologica|February 4, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia modelDina Stroopinsky, Jessica Liegel, Manoj Bhasin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapyFrances A Shepherd, Caroline Domerg, Pierre Hainaut, et al.
Pageof 6